Diabetes mellitus type 2 surgery: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
Line 10: Line 10:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Primary care]]

Revision as of 21:20, 29 July 2020

Diabetes mellitus main page

Diabetes mellitus type 2 Microchapters

Home

Patient information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Diabetes Mellitus Type 2 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical therapy

Life Style Modification
Pharmacotherapy
Glycemic Control

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Pancreas and islet cell transplantation is considered in patients with chronic diabetes who have frequent metabolic complications and are intolerant to exogenous insulin or have failed insulin therapy.

Surgery

There is no indication for surgery in type 2 diabetes mellitus unless, there is an indication for pancreas and islet cell transplantation. Pancreas and islet transplantation have been shown to normalize glucose levels but require lifelong immunosuppression to prevent graft rejection and recurrence of autoimmune islet destruction. Islet cell transplantation remains investigational. Pancreas transplantation is considered for patients with chronic diabetes and multiple complications.
Indication for pancreas transplantation is:[1]

  • Patients who have history of frequent severe metabolic derangement (hypoglycemia, marked hyperglycemia, ketoacidosis), intolerant to exogenous insulin therapy or failure of treatment with insulin.

References

  1. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE (2006). "Pancreas and islet transplantation in type 1 diabetes". Diabetes Care. 29 (4): 935. PMID 16567844.